Skip to main content
. 2024 Jan 12;13(2):e030512. doi: 10.1161/JAHA.123.030512

Table 3.

99mTc‐PYP Cardiac Data Changes Between the Eplontersen Group and the Control Group*

Semi quantitative analysis Eplontersen group (n=6) Control group (n=7) P value
Baseline planar H/CL ratio 1.561±0.105 1.701±0.171 0.234
Baseline volumetric H/L ratio 3.774±0.474 4.079±0.534 0.317
ΔPlanar H/CL ratio −0.086±0.138 −0.044±0.181 0.721
ΔVolumetric H/L ratio −0.797±0.351 −0.164±0.349 0.010
Change in planar H/CL ratio, % −5.299±8.879 −1.930±10.397 0.475
Change in volumetric H/L ratio, % −20.703±7.821 −3.402±8.128 0.007
Follow‐up time, d 607.51 [526–850] 491.00 [195–644] 0.445

99mTc‐PYP indicates technetium‐99m‐pyrophosphate; H/CL ratio, heart and contralateral lung ratio; and H/L ratio, heart and lung ratio.

*

Data are given as mean±SD or median [first quartile–third quartile].

P<0.05.

P<0.01.